Dr. Vincent Martin is an Associate Professor in Microbiology in the Department of Biology at Concordia University and holds the Canada Research Chair in Microbial Genomics and Engineering. He obtained a B.Sc. in Microbiology from McGill University (1989), an M.Sc. in Environmental Biology from the University of Guelph (1993) and a Ph.D. in Microbiology from the University of British Columbia (1999) under the supervision of Dr. Bill Mohn, where he elucidated the metabolic pathway for plant diterpene biodegradation in Pseudomonas. His post-doctoral studies were performed with Dr. Jay Keasling at the University of California, Berkeley where he engineered E. coli for over-production of amorphadiene, a precursor to the anti-malarial artemisinin. In 2003 he joined the Physical Biosciences Division of the Lawrence Berkeley National Laboratory as a Staff Scientist. The same year, with a philanthropic grant from the Bill and Melinda Gates Foundation, he co-founded Amyris Biotechnologies, one of the first biotech companies formed on the promise of synthetic biology technology where he currently serves as a scientific advisor. In 2004, he joined Concordia University as an Assistant Professor. Dr. Martin’s interests are focused on the metabolic engineering of microbes for the degradation of plant biomass and the production of commodity and high value chemicals. He is the project co-leader for a recently funded $13.6 million Genome Canada grant aimed at developing synthetic biosystems for the production of high-value plant metabolites. Dr. Martin is also the fermentation theme leader for the Agriculture & Agri Food Canada Cellulosic Biofuels and the NSERC Bioconversion Networks. In 2004 he received the Petro-Canada Young Innovator Award. He currently serves on the editorial board of the Canadian Journal of Microbiology, Bioengineered Bugs and the Water, Air and Soil Pollution Journal.